Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
Úna McMenaminBlánaid HicksCarmel HughesPeter MurchieJulia Hippisley-CoxTom RangerCarol CouplandChristopher R CardwellPublished in: BMC cancer (2021)
Our study will provide evidence to inform guidance given to women diagnosed with cancer on the safety of HRT use and/or guide modifications to clinical practice.
Keyphrases
- papillary thyroid
- cardiovascular disease
- replacement therapy
- squamous cell
- clinical practice
- randomized controlled trial
- polycystic ovary syndrome
- lymph node metastasis
- childhood cancer
- risk factors
- adipose tissue
- young adults
- smoking cessation
- coronary artery disease
- skeletal muscle
- insulin resistance
- breast cancer risk